Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Kennedy Jr. has been spotted leaving a Washington, D.C., tanning salon in recent weeks, drawing scrutiny for participating in an activity with well-known health risks, including skin cancer. In fact, ...

Skin cancer is the most common type of cancer in the U.S., and it has increased dramatically in the last 50 years. Melanoma, ...

People with locally advanced head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The U.S. Food and Drug Administration ...

Taletrectinib gains FDA approval as a groundbreaking treatment for ROS1-positive non-small cell lung cancer, offering hope for patients with CNS involvement.

Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.

The receptor for the complement component C5a may be a useful therapeutic target for cases of cutaneous squamous cell carcinoma (cSCC), according to a new report. 1 The study, published in the ...

Traws Pharma published key clinical efficacy data for rigosertib in patients with RDEB-associated squamous cell carcinoma. What is rigosertib being evaluated for?

Papillary renal cell carcinoma is a type of kidney cancer that starts in the kidneys' tubules. Read about the symptoms, diagnosis, treatment, and outlook.

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...

Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.. If you have the appropriate software ...